FDA Grants Accelerated Approval to Linvoseltamab-gcpt for Relapsed or Refractory Multiple Myeloma By Ogkologos - August 8, 2025 763 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the LINKER-MM1 study Source RELATED ARTICLESMORE FROM AUTHOR Comprehensive Genomic Profiling with Subsequent Molecularly Guided Therapy Improves Outcomes Over Platinum-based Chemotherapy in Previously Untreated, Unfavourable CUP NCI and CRUK Take on Cancer’s Toughest Problems Tebentafusp Continues to Provide Long-Term OS Benefit in Previously Untreated Patients with Unresectable or Metastatic Uveal Melanoma MOST POPULAR Women Under 35 More Likely to Have Their Breast Cancer Spread November 4, 2021 These Triplets Were Tired Of Being Mistaken For Each Other. Their... June 14, 2019 FDA Approves Alectinib as Adjuvant Treatment for ALK-positive Non-Small Cell Lung... April 25, 2024 Finally Pregnant After Struggling With Infertility For Years, She Was Diagnosed... October 25, 2019 Load more HOT NEWS Selpercatinib Shows Promise against Lung Cancers with Alterations in RET Gene Drinking Alcohol, Often Heavily, Common among People with Cancer and Long-Term... Dabrafenib–Trametinib Combination Approved for Melanoma, Anaplastic Thyroid Cancer 10 Ways to Keep Your Family Safe from the Coronavirus Outbreak
